NCBI PubMed Centralopen access
Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 251181
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.